Cartiva closes out $8M Series D to bring its synthetic cartilage product geared at osteoarthritis to U.S. market


Cartiva closes out $8M Series D to bring its synthetic cartilage product geared at osteoarthritis to U.S. market

cartiva

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.